Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A congenital stationary night blindness characterized by autosomal recessive inheritance that has material basis in homozygous mutation in the GNAT1 gene on chromosome 3p21.
Features include always present findings: Constriction of peripheral visual field, Congenital stationary night blindness, Optic disc pallor, and Rod-cone dystrophy. 5 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Congenital stationary night blindness, Visual impairment, Optic disc pallor |
GNAT1 encodes G protein subunit alpha transducin 1 (350 aa). Functions as a signal transducer for the rod photoreceptor RHO. Required for normal RHO-mediated light perception by the retina. Highest expression in Testis (2.2 TPM) and Liver (0.2 TPM).
Congenital stationary night blindness 1G is associated with mutations in the GNAT1 gene on chromosome 3.
The GNAT1 protein participates in GNAT1 (Met removed), METAP1/2 demethylates GNAT1, and NMT1/2 transfer MYS to GNAT1 pathways.
GNAT1 is classified as a druggable target (G Protein Coupled Receptor category) with score 0.0.
Genetic testing for GNAT1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for congenital stationary night blindness 1G has been reported in the published literature.
Phenotype severity distribution: 4 always present features.
No clinical trials have been registered for congenital stationary night blindness 1G.
7 publications have been identified in PubMed for congenital stationary night blindness 1G. Research spans Basic Science / Preclinical (57%), Review / Meta-Analysis (29%), and Diagnostic / Biomarker (14%).
Katanaev VL (2025). [PMID: 40745211](https://pubmed.ncbi.nlm.nih.gov/40745211/). *EMBO Mol Med*. [Review / Meta-Analysis]
Rui X (2025). [PMID: 40175531](https://pubmed.ncbi.nlm.nih.gov/40175531/). *Sci Rep*. [Diagnostic / Biomarker]
Durajczyk M (2025). [PMID: 40004769](https://pubmed.ncbi.nlm.nih.gov/40004769/). *J Clin Med*. [Review / Meta-Analysis]
Chai Z (2024). [PMID: 39656211](https://pubmed.ncbi.nlm.nih.gov/39656211/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Jiang X (2024). [PMID: 39728691](https://pubmed.ncbi.nlm.nih.gov/39728691/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 6:52 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Pregnancy and birth
1 |
Congenital stationary night blindness |
Lynn J (2024). [PMID: 39858579](https://pubmed.ncbi.nlm.nih.gov/39858579/). *Genes (Basel)*. [Basic Science / Preclinical]